<ѻý>Intensive Pretransplant Consolidation in Older AML Fails to Improve Resultsѻý> Newer therapies and strategies might show more promise for boosting survival Sep 07, 2023
<ѻý>Microdevices for Glioma; Cervical Adenocarcinoma Test; Language Gaps and Cancer Careѻý> News, features, and commentary about cancer-related issues Sep 07, 2023
<ѻý>More Intense ALL Therapy Improves Outcomes in Adolescents, Young Adultsѻý> Treatment with "pediatric-inspired protocols" improved event-free, relapse-free survival Sep 07, 2023
<ѻý>Cancer Patients More Likely to Die During COVID Pandemicѻý> Omicron wave was especially deadly, and those with blood cancers at increased risk Sep 01, 2023
<ѻý>Prayer to Cure Cancer; Exercise for Sexual Dysfunction; Carb Intake and Cancerѻý> News, features, and commentary about cancer-related issues Sep 01, 2023
<ѻý>Novel Oral Tx Shows Early Promise in Relapsed/Refractory Myelomaѻý> Mezigdomide led to 41% response rate in heavily pretreated patients Aug 30, 2023
<ѻý>U.S. Unveils First 10 Drugs for Medicare Price Negotiationsѻý> Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
<ѻý>Adenovirus May Trigger Thrombocytopenia, Thrombosis, Case Studies Suggestѻý> First reports of an anti-PF4 disorder associated with an adenovirus infection Aug 09, 2023
<ѻý>Adcetris Plus Chemo Effective in HIV-Related Hodgkin Lymphomaѻý> Researchers call study "practice changing," although outside experts urge caution Aug 04, 2023
<ѻý>Anti-PD-1 Alone Produces Durable Responses in Relapsed/Refractory PMBCLѻý> More than 80% of responding patients remained in response at 4 years Jul 24, 2023
<ѻý>New Recommendations Address Global Inequality in Sickle Cell Disease Careѻý> Commission lays out strategies for progress by 2025 and beyond Jul 13, 2023
<ѻý>Non-Covalent BTK Inhibitor Yields High Response Rate in Pretreated CLLѻý> 73% of patients with prior exposure to covalent BTK inhibitors responded Jul 05, 2023
<ѻý>FDA Gives Nod to Gene Therapy for Hemophilia Aѻý> First gene therapy approved for severe hemophilia A Jun 29, 2023
<ѻý>TXA Holds Its Own for Heavy Menstrual Bleeding in von Willebrand Diseaseѻý> In phase III study, recombinant VWF not superior to cheaper alternative for type 1 and 2 cases Jun 29, 2023
<ѻý>No OS Benefit With Ibrutinib in Early-Stage, High-Risk CLLѻý> Study suggests "watch and wait" should remain standard of care Jun 28, 2023
<ѻý>New Bispecific Antibody Approved for Tough-to-Treat Lymphomaѻý> Approval of glofitamab was based on a phase I/II study that showed a 56% overall response rate Jun 16, 2023
<ѻý>Base-Edited CAR-T Product 'Potent' in Relapsed Childhood T-Cell ALLѻý> One young patient achieved molecular remission within 28 days of infusion Jun 14, 2023
<ѻý>Pre-Existing Depression, Anxiety Tied to Worse DLBCL Prognosisѻý> Patients with depression alone had the worst overall survival Jun 13, 2023
<ѻý>CRISPR Therapy Exceeds Targets in Thalassemia, Sickle Cell Diseaseѻý> Results "indicate that exa-cel can provide a one-time functional cure," says researcher Jun 13, 2023
<ѻý>CAR-T for Chronic Lymphocytic Leukemia Hits Goal of Mid-Stage Trialѻý> All patients had progressed on BTK inhibitors and most had failed venetoclax Jun 12, 2023
<ѻý>Skipping Radiotherapy 'Seems Safe' for PMBCL Patients in Remissionѻý> PET-negative patients after chemoimmunotherapy fared well with observation alone Jun 07, 2023
<ѻý>Second-Line Axi-Cel Bests Standard in Relapsed/Refractory Large B-Cell Lymphomaѻý> The CAR T-cell therapy led to significantly longer overall survival Jun 05, 2023
<ѻý>New Agents for Relapsed/Refractory Myeloma Impress in Early-Stage Clinical Trialsѻý> High rates of deep, durable response with bispecific antibody, rapidly produced CAR T-cell agents Jun 05, 2023
<ѻý>Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDSѻý> Results suggest a "paradigm shift" in the treatment of anemia for these patients May 25, 2023
<ѻý>Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patientsѻý> 5-year OS increased to 100% in standard-risk ALL patients at a Tijuana hospital May 25, 2023
<ѻý>Adding Mylotarg to Chemo Fails to Boost Survival in NPM1-Mutated AMLѻý> But trial detects "meaningful benefit" when it comes to relapse, editorialists say May 15, 2023
<ѻý>Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomasѻý> Results will likely "encourage a practice change," editorialists say May 10, 2023
<ѻý>FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemiaѻý> Median OS improved from 15 months to nearly 32 months with quizartinib May 09, 2023
<ѻý>Mysterious White Blood Cell Disorder Not Just 'AIDS Without HIV'ѻý> Idiopathic CD4 lymphocytopenia not so heterogenous after all May 03, 2023
<ѻý>Sodium Thiosulphate Not Much Help for Calciphylaxis in CKDѻý> Though used off-label for years, treatment isn't very beneficial Apr 26, 2023
<ѻý>Blinatumomab Plus Chemo Effective in Aggressive Infant ALLѻý> Low incidence of relapse after treatment "remarkable," researchers say Apr 26, 2023
<ѻý>Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCLѻý> Adding polatuzumab vedotin to a modified version of R-CHOP significantly improved PFS Apr 20, 2023
<ѻý>Novel Antibody Induces Durable Responses in Heavily Pretreated Myelomaѻý> Overall response rate of 90% in patients who received highest doses of REGN5459 Apr 18, 2023
<ѻý>Oral Drug Improves Sunlight Tolerance in Genetic Photosensitivity Disordersѻý> Dersimelagon significantly extended time to sun-related prodromal symptoms Apr 12, 2023
<ѻý>Blood Donor's Sex Makes No Difference for Survivalѻý> Only difference seen was higher incidence of MRSA infection in recipients of female donor blood Apr 12, 2023
<ѻý>SYK Inhibitor Promising in Early Trial of Primary ITPѻý> Sovleplenib demonstrated "consistent response" as second-line treatment Apr 11, 2023
<ѻý>Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosisѻý> Median overall survival reached 20 years with interferon alfa-2b in low-grade disease Apr 05, 2023
<ѻý>FDA Greenlights First Drug for Rare Immunodeficiency Diseaseѻý> Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
<ѻý>Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosisѻý> A 52-year-old man visited his doctor for a new growth on his nose. Can you diagnosis the patient? Mar 27, 2023
<ѻý>Sam Neill's Rare Lymphomaѻý> The actor noticed swollen glands while on tour for "Jurassic World Dominion" Mar 23, 2023